During analysis of the expression pattern of DLEU7-AS1 in the different karyotypic classifications, we revealed that DLEU7-AS1 expression was markedly reduced in patients with AML with favorable/intermediate karyotypes, but not in patients with poor karyotypes. This evidence concerns the gene DLEU7 and acute myeloid leukemia.